The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China

Abstract Background COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to recei...

Full description

Bibliographic Details
Main Authors: Xi-Ru Zhang, Zhi-Ju Li, Qi Fu, Jin-Dong Wang, Qing-Mei Huang, Wei-Qi Song, Xiao-Yu Xu, Zhi-Hao Li, Chen Mao
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-023-15294-7
_version_ 1797863318936879104
author Xi-Ru Zhang
Zhi-Ju Li
Qi Fu
Jin-Dong Wang
Qing-Mei Huang
Wei-Qi Song
Xiao-Yu Xu
Zhi-Hao Li
Chen Mao
author_facet Xi-Ru Zhang
Zhi-Ju Li
Qi Fu
Jin-Dong Wang
Qing-Mei Huang
Wei-Qi Song
Xiao-Yu Xu
Zhi-Hao Li
Chen Mao
author_sort Xi-Ru Zhang
collection DOAJ
description Abstract Background COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness. Methods A cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated. Results Among 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated. Conclusion Although the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination.
first_indexed 2024-04-09T22:33:42Z
format Article
id doaj.art-379536258f16417e836ea1da469643c2
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-04-09T22:33:42Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-379536258f16417e836ea1da469643c22023-03-22T12:36:32ZengBMCBMC Public Health1471-24582023-03-0123111010.1186/s12889-023-15294-7The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in ChinaXi-Ru Zhang0Zhi-Ju Li1Qi Fu2Jin-Dong Wang3Qing-Mei Huang4Wei-Qi Song5Xiao-Yu Xu6Zhi-Hao Li7Chen Mao8Department of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityDepartment of Epidemiology, School of Public Health, Southern Medical UniversityAbstract Background COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness. Methods A cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated. Results Among 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated. Conclusion Although the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination.https://doi.org/10.1186/s12889-023-15294-7Coronavirus disease 2019VaccinationCoverageWillingnessRelated factor
spellingShingle Xi-Ru Zhang
Zhi-Ju Li
Qi Fu
Jin-Dong Wang
Qing-Mei Huang
Wei-Qi Song
Xiao-Yu Xu
Zhi-Hao Li
Chen Mao
The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
BMC Public Health
Coronavirus disease 2019
Vaccination
Coverage
Willingness
Related factor
title The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_full The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_fullStr The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_full_unstemmed The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_short The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
title_sort coverage of sars cov 2 vaccination and the willingness to receive the sars cov 2 variant vaccine among employees in china
topic Coronavirus disease 2019
Vaccination
Coverage
Willingness
Related factor
url https://doi.org/10.1186/s12889-023-15294-7
work_keys_str_mv AT xiruzhang thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT zhijuli thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT qifu thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT jindongwang thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT qingmeihuang thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT weiqisong thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT xiaoyuxu thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT zhihaoli thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT chenmao thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT xiruzhang coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT zhijuli coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT qifu coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT jindongwang coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT qingmeihuang coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT weiqisong coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT xiaoyuxu coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT zhihaoli coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina
AT chenmao coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina